Sesen Bio, Inc. (SESN) earnings
Quarterly and annual SESN reports and results, each read against the price at its own news timestamp. Back to the SESN overview →
2 measured SESN earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K Carisma Therapeutics For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q Carisma Therapeutics For: Sep 30 | SEC filing · Form 10-Q | — | — |
Keep exploring
More SESN: analyst actions → · SEC filings → · SESN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Enochian Biosciences, Inc. (ENOB) | 712 | 0.00% | 42% |
| LIFEPOINT HEALTH INC COMMON (LPNT) | 709 | +0.01% | 51% |
| The Ensign Group, Inc. (ENSG) | 706 | +0.04% | 52% |
| Pluristem Therapeutics, Inc. (PSTI) | 704 | -0.23% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.